Established in December 2008, BLIRT is a leading Polish biotechnology company  focusing on in-house R&D (oncology and antifungal) and contract research services. As a high quality and customer-focused company, BLIRT provides a broad portfolio of services throughout the drug R&D process. Offered services are designed to help the customers to shorten the discovery and development time and lower the cost of drug and medical device R&D through cost-effective and efficient outsourcing solutions.

The company built its initial capabilities around discovery chemistry and has further enhanced the integrated services with analytical services, bio-analytical services, process research, DMPK/ADME, toxicology, genomic services, biologics manufacturing services, antibody and biological research reagent manufacturing.